These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 27121231

  • 1. A benzenediamine derivate FC-99 attenuates lupus nephritis in MRL/lpr mice via inhibiting myeloid dendritic cell-secreted BAFF.
    Ji J, Xu J, Li F, Li X, Gong W, Song Y, Dou H, Hou Y.
    Acta Biochim Biophys Sin (Shanghai); 2016 May; 48(5):411-9. PubMed ID: 27121231
    [Abstract] [Full Text] [Related]

  • 2. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J, Fan H, Li F, Li X, Dong G, Gong W, Song Y, Liu F, Hua C, Tan R, Dou H, Hou Y.
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [Abstract] [Full Text] [Related]

  • 3. Oridonin ameliorates lupus-like symptoms of MRL(lpr/lpr) mice by inhibition of B-cell activating factor (BAFF).
    Zhou L, Sun L, Wu H, Zhang L, Chen M, Liu J, Zhong R.
    Eur J Pharmacol; 2013 Sep 05; 715(1-3):230-7. PubMed ID: 23712004
    [Abstract] [Full Text] [Related]

  • 4. A novel BAFF antagonist, BAFF-Trap, effectively alleviates the disease progression of systemic lupus erythematosus in MRL/lpr mice.
    Yu C, Chen S, Zhou B, Zhang H, Su X, Luo Y, Yang L.
    Mol Immunol; 2021 Jan 05; 129():1-11. PubMed ID: 33254074
    [Abstract] [Full Text] [Related]

  • 5. Curcumin attenuates lupus nephritis in MRL/lpr mice by suppressing macrophage-secreted B cell activating factor (BAFF).
    Li Q, Tan S, Xu K, Fu X, Yu J, Yang H, Wang H.
    Int J Clin Exp Pathol; 2019 Jan 05; 12(6):2075-2083. PubMed ID: 31934029
    [Abstract] [Full Text] [Related]

  • 6. Renal tubular epithelial cell-derived BAFF expression mediates kidney damage and correlates with activity of proliferative lupus nephritis in mouse and men.
    Schwarting A, Relle M, Meineck M, Föhr B, Triantafyllias K, Weinmann A, Roth W, Weinmann-Menke J.
    Lupus; 2018 Feb 05; 27(2):243-256. PubMed ID: 28659046
    [Abstract] [Full Text] [Related]

  • 7. Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation.
    Ma X, Che N, Gu Z, Huang J, Wang D, Liang J, Hou Y, Gilkeson G, Lu L, Sun L.
    Cell Transplant; 2013 Feb 05; 22(12):2279-90. PubMed ID: 23127285
    [Abstract] [Full Text] [Related]

  • 8. A new benzenediamine derivative modulates Toll-like receptors-induced myeloid dendritic cells activation and ameliorates lupus-like syndrome in MRLlpr/lpr mice.
    Gao S, Gong Y, Ji J, Yuan L, Han L, Guo Y, Fan X, Hou Y, Hua C.
    Eur J Pharmacol; 2017 May 15; 803():94-102. PubMed ID: 28342978
    [Abstract] [Full Text] [Related]

  • 9. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
    Chalmers SA, Glynn E, Garcia SJ, Panzenbeck M, Pelletier J, Dimock J, Seccareccia E, Bosanac T, Khalil S, Harcken C, Webb D, Nabozny G, Fine JS, Souza D, Klein E, Herlitz L, Ramanujam M, Putterman C.
    Clin Immunol; 2018 Dec 15; 197():205-218. PubMed ID: 30339790
    [Abstract] [Full Text] [Related]

  • 10. Unexpected development of autoimmunity in BAFF-R-mutant MRL-lpr mice.
    Ju ZL, Shi GY, Zuo JX, Zhang JW, Jian Sun.
    Immunology; 2007 Feb 15; 120(2):281-9. PubMed ID: 17073941
    [Abstract] [Full Text] [Related]

  • 11. Activation of toll-like receptor-7 exacerbates lupus nephritis by modulating regulatory T cells.
    Gong L, Wang Y, Zhou L, Bai X, Wu S, Zhu F, Zhu YF.
    Am J Nephrol; 2014 Feb 15; 40(4):325-44. PubMed ID: 25341693
    [Abstract] [Full Text] [Related]

  • 12. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
    Mannoor K, Matejuk A, Xu Y, Beardall M, Chen C.
    J Immunol; 2012 Apr 15; 188(8):3628-38. PubMed ID: 22407922
    [Abstract] [Full Text] [Related]

  • 13. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.
    J Immunol; 2011 Sep 15; 187(6):3413-21. PubMed ID: 21849682
    [Abstract] [Full Text] [Related]

  • 14. Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models.
    Sugahara K, Maeda Y, Shimano K, Murase M, Mochiduki S, Takemoto K, Kakimoto T, Utsumi H, Oshita K, Kataoka H.
    J Immunol Res; 2019 Sep 15; 2019():5821589. PubMed ID: 31930150
    [Abstract] [Full Text] [Related]

  • 15. Triggering receptor expressed on myeloid cells-1 (TREM-1) deficiency augments BAFF production to promote lupus progression.
    Liu CJ, Tsai CY, Chiang SH, Tang SJ, Chen NJ, Mak TW, Sun GH, Sun KH.
    J Autoimmun; 2017 Mar 15; 78():92-100. PubMed ID: 28089248
    [Abstract] [Full Text] [Related]

  • 16. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
    Su B, Ye H, You X, Ni H, Chen X, Li L.
    Life Sci; 2018 Sep 01; 208():26-32. PubMed ID: 30146016
    [Abstract] [Full Text] [Related]

  • 17. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
    Patole PS, Gröne HJ, Segerer S, Ciubar R, Belemezova E, Henger A, Kretzler M, Schlöndorff D, Anders HJ.
    J Am Soc Nephrol; 2005 May 01; 16(5):1326-38. PubMed ID: 15772251
    [Abstract] [Full Text] [Related]

  • 18. Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus.
    Dong G, Yang Y, Li X, Yao X, Zhu Y, Zhang H, Wang H, Ma Q, Zhang J, Shi H, Ning Z, Yan F, Zhai W, Dai J, Li Z, Li C, Ming J, Xue Q, Meng X, Si C, Xiong H.
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan 01; 1866(1):165554. PubMed ID: 31513833
    [Abstract] [Full Text] [Related]

  • 19. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
    Jiang C, Zhao ML, Scearce RM, Diaz M.
    Arthritis Rheum; 2011 Apr 01; 63(4):1086-96. PubMed ID: 21225690
    [Abstract] [Full Text] [Related]

  • 20. CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.
    Chalmers SA, Wen J, Shum J, Doerner J, Herlitz L, Putterman C.
    Clin Immunol; 2017 Dec 01; 185():100-108. PubMed ID: 27570219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.